Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke. (Q33300303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

M A Yenari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

L K Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

G H Sun

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

D Kunis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

D Chang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

G W Albers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

M E Moseley

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

G K Steinberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

Journal of Stroke and Cerebrovascular Diseases

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

179-186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Pharmacokinetic and thrombolytic properties of unglycosylated recombinant tissue-type plasminogen activator (BM 06.021) produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Coronary Thrombolytic Properties of a Novel Recombinant Plasminogen Activator (BM 06.022) in a Canine Model

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Perfusion and diffusion MR imaging of thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Evaluation of recombinant tissue plasminogen activator in embolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Tissue plasminogen activator reduces neurological damage after cerebral embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Diffusion-weighted magnetic resonance imaging characteristics of hemorrhagic transformation in experimental embolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Perfusion and Diffusion-Weighted MR Imaging for In Vivo Evaluation of Treatment With U74389G in a Rat Stroke Model

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

A rat model of reproducible cerebral infarction using thrombotic blood clot emboli

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980004-9

7 January 2021

10.1016/S1052-3057(98)80004-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895078%20AND%20SRC:MED&resulttype=core&format=json

release_vqjf5jj3mzdlzna456vodl6rma

8 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vqjf5jj3mzdlzna456vodl6rma

24 November 2022

mapped directly with Wikidata item

1 reference